T501-0421 Screening compound: 3-(3-{[4-(propan-2-yl)-4H-1,2,4-triazol-3-yl]methyl}piperidine-1-carbonyl)-1H-indazole

T501-0421 Screening compound: 3-(3-{[4-(propan-2-yl)-4H-1,2,4-triazol-3-yl]methyl}piperidine-1-carbonyl)-1H-indazole
T501-0421 Screening compound: 3-(3-{[4-(propan-2-yl)-4H-1,2,4-triazol-3-yl]methyl}piperidine-1-carbonyl)-1H-indazole alternative view

Chemical Structure Depiction of ChemDiv screening compound T501-0421
3-(3-{[4-(propan-2-yl)-4H-1,2,4-triazol-3-yl]methyl}piperidine-1-carbonyl)-1H-indazole

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T501-0421

Molecular Formula

C19H24N6O (C19 H24 N6 O)

Compound Name

3-(3-{[4-(propan-2-yl)-4H-1,2,4-triazol-3-yl]methyl}piperidine-1-carbonyl)-1H-indazole

IUPAC name

3-(3-{[4-(propan-2-yl)-4H-124-triazol-3-yl]methyl}piperidine-1-carbonyl)-1H-indazole

SMILES

CC(C)n1c(CC(CCC2)CN2C(c2n[nH]c3c2cccc3)=O)nnc1

InChI

InChI=1S/C19H24N6O/c1-13(2)25-12-20-22-17(25)10-14-6-5-9-24(11-14)19(26)18-15-7-3-4-8-16(15)21-23-18/h3-4,7-8,12-14H,5-6,9-11H2,1-2H3,(H,21,23)/t14-/m1/s1

InChI Key

SCKBXTOATJRXMJ-CQSZACIVSA-N

MDL Number (MFCD)

MFCD29009998

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

352.44

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.245

Distribution Coefficient, logD

2.244

Water Solubility, LogSw

-2.75

Polar Surface Area

66.191

Acid Dissociation Constant (pKa)

14.84

Base Dissociation Constant (pKb)

4.49

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

47.40

T501-0421 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

Bcl2-PPI Inhibitors Library (12246 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS Targets (44014 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Hemic and lymphatic
  • Nervous system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Cyclic compounds
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with T501-0421 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound T501-0421?
Check Price and Availability of T501-0421, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of T501-0421 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for T501-0421
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for T501-0421
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of T501-0421 available by request